Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

APO-ALPRAZ TABLET 0.25 mg - HSA Drug Approval Details

Approvals/HSA/APO-ALPRAZ TABLET 0.25 mg

Approved

THERAPEUTIC

APO-ALPRAZ TABLET 0.25 mg

APOTEX INCApotex Inc.🇸🇬 Health Sciences Authority

Approval Date: Oct 6, 1994
Approval ID: 039aec471b5e5ea9
Company: APOTEX INCApotex Inc.
Type: Therapeutic

Approval Details

Approval Id: 039aec471b5e5ea9
Drug Name: APO-ALPRAZ TABLET 0.25 mg
Product Name: APO-ALPRAZ TABLET 0.25 mg
Approval Number: SIN07872P
Approval Date: 1994-10-06
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Licence Holder: PHARMAFORTE SINGAPORE PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: N05BA12
Atc Item Name: alprazolam
Pharma Manufacturer Name: PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path: /organization/pharmaforte-singapore-pte-ltd

Active Ingredients

ALPRAZOLAM

0.25 mg

ALPRAZOLAM

0.25 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 6, 1994

Approval ID

039aec471b5e5ea9

Type

Therapeutic

Back to HSA Approvals